View in EDS HTML Full Text PDF Full Text

Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.

Saved in:
Bibliographic Details
Title: Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
Authors: Vermeire, Séverine1 (AUTHOR) Severine.Vermeire@uzleuven.be, Hanzel, Jurij2 (AUTHOR), Löwenberg, Mark3 (AUTHOR), Ferrante, Marc1 (AUTHOR), Bossuyt, Peter4 (AUTHOR), Hoentjen, Frank5,6 (AUTHOR), Franchimont, Denis7 (AUTHOR), Palatka, Károly8 (AUTHOR), Peeters, Harald9 (AUTHOR), Mookhoek, Aart10 (AUTHOR), Hertogh, Gert de11 (AUTHOR), Molnár, Tamás12 (AUTHOR), Moerkercke, Wouter van1,13 (AUTHOR), Lobatón, Triana14,15 (AUTHOR), Clasquin, Esmé3 (AUTHOR), Hulshoff, Melanie S3 (AUTHOR), Baert, Filip16 (AUTHOR), D'Haens, Geert3 (AUTHOR), group, LOVE-UC study (AUTHOR)
Source: Journal of Crohn's & Colitis. Apr2024, Vol. 18 Issue 4, p540-547. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18739946
DOI:10.1093/ecco-jcc/jjad179